Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1079) 1079
science & technology (843) 843
life sciences & biomedicine (815) 815
male (545) 545
female (490) 490
aspergillosis, allergic bronchopulmonary - drug therapy (481) 481
aspergillosis (409) 409
adult (366) 366
antifungal agents - therapeutic use (361) 361
middle aged (335) 335
biological and medical sciences (287) 287
medical sciences (284) 284
allergic bronchopulmonary aspergillosis (274) 274
infectious diseases (264) 264
aspergillosis, allergic bronchopulmonary - diagnosis (252) 252
respiratory system (247) 247
cystic fibrosis (218) 218
asthma (209) 209
aged (203) 203
mycoses (199) 199
pulmonary aspergillosis (195) 195
aspergillosis, allergic bronchopulmonary - complications (187) 187
aspergillosis - drug therapy (180) 180
immunology (177) 177
aspergillus fumigatus (173) 173
aspergillus (166) 166
microbiology (165) 165
abridged index medicus (163) 163
adolescent (158) 158
child (148) 148
itraconazole (142) 142
treatment outcome (141) 141
allergy (133) 133
antifungal agents (130) 130
cystic fibrosis - complications (129) 129
animals (128) 128
general & internal medicine (124) 124
aspergillosis, allergic bronchopulmonary - immunology (121) 121
diagnosis (120) 120
patients (119) 119
risk factors (117) 117
aspergillosis - diagnosis (116) 116
itraconazole - therapeutic use (114) 114
diagnosis, differential (109) 109
care and treatment (106) 106
aspergillus fumigatus - isolation & purification (105) 105
tomography, x-ray computed (103) 103
health aspects (100) 100
aspergillosis - microbiology (99) 99
human mycoses (99) 99
voriconazole (97) 97
mycology (96) 96
aspergillus fumigatus - immunology (95) 95
lung diseases (94) 94
amphotericin b - therapeutic use (90) 90
retrospective studies (90) 90
fungi (89) 89
antifungal agents - administration & dosage (87) 87
aspergillosis, allergic bronchopulmonary - microbiology (86) 86
pharmacology. drug treatments (86) 86
aspergillosis, allergic bronchopulmonary - etiology (82) 82
asthma - complications (81) 81
pharmacology & pharmacy (81) 81
research (81) 81
adrenal cortex hormones - therapeutic use (79) 79
drug therapy (78) 78
internal medicine (75) 75
immunocompromised host (73) 73
lung diseases, fungal - drug therapy (72) 72
chronic disease (71) 71
immunoglobulin e (71) 71
asthma - drug therapy (70) 70
aspergillosis, allergic bronchopulmonary - diagnostic imaging (68) 68
aspergillus fumigatus - drug effects (68) 68
infections (68) 68
medicine, general & internal (68) 68
pediatrics (66) 66
triazoles - therapeutic use (66) 66
young adult (66) 66
amphotericin b (65) 65
drug therapy, combination (64) 64
aspergillosis - immunology (63) 63
aspergillus - isolation & purification (63) 63
corticosteroids (63) 63
immunoglobulin e - blood (63) 63
medicine & public health (63) 63
mortality (63) 63
prednisone - therapeutic use (63) 63
tuberculosis (62) 62
pulmonary aspergillosis - drug therapy (60) 60
radiography (60) 60
research article (60) 60
antifungal agents - pharmacology (59) 59
epidemiology (59) 59
antibiotics. antiinfectious agents. antiparasitic agents (58) 58
fungal infections (58) 58
aged, 80 and over (57) 57
medical research (57) 57
pneumonia (57) 57
invasive aspergillosis (56) 56
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1323) 1323
French (43) 43
German (30) 30
Japanese (28) 28
Spanish (14) 14
Italian (7) 7
Russian (7) 7
Chinese (5) 5
Danish (4) 4
Polish (4) 4
Dutch (3) 3
Finnish (2) 2
Portuguese (2) 2
Turkish (2) 2
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis-State of the Art: Cystic Fibrosis Foundation Consensus Conference
by David A. Stevens and Richard B. Moss and Viswanath P. Kurup and Alan P. Knutsen and Paul Greenberger and Marc A. Judson and David W. Denning and Reto Crameri and Alan S. Brody and Michael Light and Marianne Skov and William Maish and Gianni Mastella and The Cystic Fibrosis Foundation Consensus Conference and Cystic Fibrosis Fdn Consensus Conf and Participants in the Cystic Fibrosis Foundation Consensus Conference and participants in the Cystic Fibrosis Foundation Consensus Conference
Clinical infectious diseases, ISSN 1058-4838, 10/2003, Volume 37, Issue 3, pp. S225 - S264
T lymphocytes | Aspergillus | Allergens | Antigens | Lungs | Antibodies | Cystic fibrosis | Allergic bronchopulmonary aspergillosis | Asthma | Eosinophils | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Congresses as Topic | Animals | Cystic Fibrosis - microbiology | Humans | Aspergillus fumigatus | Cystic Fibrosis - complications | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Aspergillosis, Allergic Bronchopulmonary - etiology | Antifungal Agents - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Allergic bronchopulmonary aspergillosis
by Greenberger, Paul A
Journal of allergy and clinical immunology, ISSN 0091-6749, 11/2002, Volume 110, Issue 5, pp. 685 - 692
IgE antibody | lymphocytes | Aspergillosis | sinusitis | end-stage | eosinophils | Aspergillus fumigatus | prednisone | bronchiectasis | Lymphocytes | Bronchiectasis | Prednisone | End-stage | Sinusitis | Eosinophils | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Immunopathology | Human mycoses | Infectious diseases | Respiratory and ent allergic diseases | Mycoses of the respiratory system | Mycoses | Biological and medical sciences | Allergic diseases | Medical sciences | Aspergillus - immunology | Humans | Aspergillus - growth & development | Tomography, X-Ray Computed | Antigens, Fungal - immunology | Cystic Fibrosis - complications | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Immunoglobulin E - immunology | Asthma - complications | Aspergillosis, Allergic Bronchopulmonary - immunology | Adult | Female | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Viral antibodies | Medical colleges | Immunoglobulins | Corticosteroids | Pulmonary aspergillosis | Immunoglobulin E | Antibodies | Cystic fibrosis | Asthma | Chemotherapy | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Allergic bronchopulmonary aspergillosis and omalizumab
by Tillie‐Leblond, I and Germaud, P and Leroyer, C and Tétu, L and Girard, F and Devouassoux, G and Grignet, J.‐P and Prudhomme, A and Dusser, D and Wallaert, B
Allergy (Copenhagen), ISSN 0105-4538, 09/2011, Volume 66, Issue 9, pp. 1254 - 1256
allergic bronchopulmonary | asthma | aspergillus | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Antibodies, Anti-Idiotypic - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Omalizumab | Aspergillosis, Allergic Bronchopulmonary - physiopathology | Male | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Aged | Prednisolone - therapeutic use | Antibodies, Anti-Idiotypic - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Mycoses | Index Medicus | Anti-Asthmatic Agents | Anti-Inflammatory Agents | Aspergillosis, Allergic Bronchopulmonary | Life Sciences | Antibodies, Monoclonal, Humanized | Antibodies, Anti-Idiotypic | Prednisolone
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
by Jat, Kana R and Walia, Dinesh K and Khairwa, Anju and Jat, Kana R
Cochrane library, ISSN 1469-493X, 03/2018, Volume 2018, Issue 3, pp. CD010288 - CD010288
Lungs & airways | Antibody treatment | Omalizumab | TREATMENT | Antibodies, Anti‐Idiotypic | Asthma (chronic): other medications | Allergic aspergillosis | Antibodies, Monoclonal, Humanized | Early Termination of Clinical Trials | Infectious disease | Asthma (chronic) | Child health | Fibrosis: cystic fibrosis | Antifungal Agents | PULMONARY INFECTION | Other medications | Itraconazole | Genetic disorders | Anti‐Allergic Agents | Cystic Fibrosis | Aspergillosis, Allergic Bronchopulmonary | Allergy & intolerance | Cystic fibrosis: other treatments | Randomized Controlled Trials as Topic | Respiratory infections | Aspergillosis | FUNGAL INFECTION | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | Medicine General & Introductory Medical Sciences | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Anti-Idiotypic - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Omalizumab - adverse effects | Humans | Cystic Fibrosis - complications | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Antifungal Agents - therapeutic use | Anti-Allergic Agents - therapeutic use | Itraconazole - therapeutic use | Anti-Allergic Agents - adverse effects | Omalizumab - therapeutic use | Antibodies, Anti-Idiotypic - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - etiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature
by Li, Jian-Xiong and Fan, Li-Chao and Li, Man-Hui and Cao, Wei-Jun and Xu, Jin-Fu
Respiratory medicine, ISSN 0954-6111, 2016, Volume 122, pp. 33 - 42
Pulmonary/Respiratory | Prednisone dosage | Omalizumab | Allergy bronchopulmonary aspergillosis | Aspergillus fumigates | exacerbation | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Aspergillus fumigatus - drug effects | Immunoglobulin E - drug effects | Asthma - prevention & control | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Treatment Outcome | Anti-Allergic Agents - pharmacology | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Asthma - drug therapy | Omalizumab - administration & dosage | Immunoglobulin E - blood | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacology | Omalizumab - pharmacology | Adolescent | Adult | Female | Aged | Child | Anti-Allergic Agents - administration & dosage | Immunoglobulin E | Medical colleges | Pulmonary aspergillosis | Analysis | Corticosteroids | Nitric oxide | Cystic fibrosis | Interferon | Biological response modifiers | Studies | Allergies | Age | Binding sites | Asthma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis
by Altman, Matthew C., MD and Lenington, Jake, MD and Bronson, Steve, RN and Ayars, Andrew G., MD
The journal of allergy and clinical immunology in practice (Cambridge, MA), ISSN 2213-2198, 2017, Volume 5, Issue 4, pp. 1137 - 1139
Internal Medicine | Allergy and Immunology | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Respiratory Insufficiency | Recurrence | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Adrenal Cortex Hormones - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Hypersensitivity - drug therapy | Antifungal Agents - therapeutic use | Anti-Allergic Agents - therapeutic use | Aspergillus fumigatus - immunology | Hypersensitivity - diagnosis | Female | Omalizumab - therapeutic use | Drug Therapy, Combination | Drug Resistance | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Activities of daily living | Leukocytes (eosinophilic) | Lung diseases | Hypersensitivity | Granulomatosis | Immunoglobulin E | Cystic fibrosis | Prednisone | Bronchiectasis | Allergic bronchopulmonary aspergillosis | Allergies | Asthma | Side effects | Dyspnea | Interleukin 5 | Aspergillosis | Monoclonal antibodies | Drug therapy | Steroid hormones
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
by Agarwal, Ritesh and Aggarwal, Ashutosh N and Dhooria, Sahajal and Sehgal, Inderpaul Singh and Garg, Mandeep and Saikia, Biman and Behera, Digambar and Chakrabarti, Arunaloke
The European respiratory journal, ISSN 0903-1936, 02/2016, Volume 47, Issue 2, pp. 490 - 498
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Glucocorticoids - administration & dosage | Prednisolone - administration & dosage | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Aspergillosis, Allergic Bronchopulmonary - physiopathology | Male | Tomography, X-Ray Computed | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Forced Expiratory Volume | Young Adult | Bronchiectasis - diagnostic imaging | Adult | Female | Aspergillosis, Allergic Bronchopulmonary - diagnostic imaging | Severity of Illness Index | Acute Disease | Bronchiectasis - drug therapy | Asthma - physiopathology | Treatment Outcome | Asthma - diagnostic imaging | Asthma - drug therapy | Disease Progression | Vital Capacity | Bronchiectasis - complications | Asthma - complications | Bronchiectasis - physiopathology
Journal Article
Details down arrow
8. Full Text Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
by Elphick, Heather E and Southern, Kevin W and Elphick, Heather E
Cochrane library, ISSN 1469-493X, 11/2016, Volume 2016, Issue 11, pp. CD002204 - CD002204
Antifungals | Respiratory infections in general | Genetic disorders | Lungs & airways | Cystic Fibrosis | Aspergillosis, Allergic Bronchopulmonary | Allergy & intolerance | TREATMENT | Cystic fibrosis: other treatments | Respiratory infections: general treatment | Allergic aspergillosis | Infectious disease | Child health | Respiratory infections | Aspergillosis | FUNGAL INFECTION | Fibrosis: cystic fibrosis | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | Antifungal Agents | Aspergillus fumigatus | Medicine General & Introductory Medical Sciences | PULMONARY INFECTION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aspergillus fumigatus - drug effects | Humans | Adult | Cystic Fibrosis - complications | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Child | Antifungal Agents - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Treating allergic bronchopulmonary aspergillosis: The way forward
by Moss, Richard B
The European respiratory journal, ISSN 0903-1936, 02/2016, Volume 47, Issue 2, pp. 385 - 387
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Asthma - drug therapy | Humans | Antifungal Agents - therapeutic use | Aspergillosis - drug therapy
Journal Article
Details down arrow
10. Full Text Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long-term outcomes
by Agarwal, Ritesh and Garg, Mandeep and Aggarwal, Ashutosh N and Saikia, Biman and Gupta, Dheeraj and Chakrabarti, Arunaloke
Respiratory medicine, ISSN 0954-6111, 2012, Volume 106, Issue 7, pp. 942 - 947
Pulmonary/Respiratory | Bronchiectasis | Glucocorticoids | ABPA | Allergic bronchopulmonary aspergillosis | Aspergillus fumigatus | Asthma | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Human mycoses | Infectious diseases | Respiratory system : syndromes and miscellaneous diseases | Mycoses | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Miscellaneous mycoses | Pneumology | Recurrence | Glucocorticoids - therapeutic use | Asthma - physiopathology | Forced Expiratory Volume - physiology | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Aspergillosis, Allergic Bronchopulmonary - physiopathology | Male | Tomography, X-Ray Computed | Treatment Outcome | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Immunoglobulin E - blood | Antigens, Fungal - blood | Asthma - complications | Aspergillus fumigatus - immunology | Vital Capacity - physiology | Bronchiectasis - prevention & control | Physical Examination | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights